Skip to Content

View Additional Section Content

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Long-term Safety and Efficacy of Darbepoetin Alfa Administered at 500 µg Once-Every-3-Weeks in Anemic Subjects With Advanced Stage Non-small Cell Lung Cancer Receiving Multi-cycle Chemotherapy

For more information on this trial, click the link below.

https://clinicaltrials.gov/ct2/show/NCT00858364?term=NCT00858364&rank=1

Principal Investigator(s)
Joseph L. Potz, M.D.

Clinical Trial Categories

  • Lung Cancer
Contact
Diane Foley, CCRP at 215-692-3213

Location

  • Abington Hematology Oncology Associates
    201 Gibraltar Rd, Ste 120
    Horsham, PA 19044
    Office: 215-692-3213

Find a Physician
Search Our Directory

215-481-MEDI
215-481-6334

Schedule a
Test

215-481-EXAM
215-481-3926